Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.

Latest updates to the Moderna Press Releases page
- CheckyesterdayChange DetectedThe latest press release announces a new Chief Operating Officer role tied to Moderna’s expansion into oncology, replacing an older Phase 1 cancer-therapy trial announcement in the displayed list. The accompanying stock quote and trading volume also changed.SummaryDifference1%

- Check8 days agoChange DetectedA new stock price and trading volume are added, and a new press release headline about ESMO 2026 is posted for September 21, 2026. The deletions remove older stock figures and a prior quarterly results post, updating the page's investor news timeline.SummaryDifference1%

- Check15 days agoChange DetectedThe header stock quote and trading volume updated from $143.97 / 15.41M to $154.04 / 20.24M, reflecting the latest market data displayed on the page.SummaryDifference0.4%

- Check23 days agoChange DetectedThe page's stock data updated from $145.55 with 14.97M shares to $143.97 with 15.41M shares.SummaryDifference0.4%

- Check29 days agoChange DetectedStock price updated to $145.55 with volume 14.97M. A new press release announcing Moderna's presentation at September 2026 conferences (Sept 1, 2026) has been added, and the prior leadership announcement about Michael McDonnell has been removed (July 8, 2026).SummaryDifference1%

- Check36 days agoChange DetectedAdded new press releases to the News and Blog Posts list, including pricing for a $2.6B convertible notes offering, FDA approval for updated 2026-2027 COVID-19 vaccines, and a private placement; older items such as Science Day highlights and advisory committee votes were removed from the listing.SummaryDifference5%

Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.